IXICO plc (AIM:IXI)
London · Delayed Price · Currency is GBP · Price in GBX 8.50
+0.75 (9.68%)
Oct 15, 2026, 9:05 AM GMT
IXICO Market Cap
IXICO has a market cap or net worth of 18.61 million as of October 15, 2026. It is the 36,173rd most valuable company in the world and the 775th biggest in the United Kingdom. Its market cap has increased by 67.38% in one year.
Market Cap
18.61M
Enterprise Value
17.50M
Revenue
7.28M
Global Rank
Country Rank
#775 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since October 15, 2013, IXICO's market cap has increased from 8.82M to 18.61M, an increase of 110.98%. That is a compound annual growth rate of 5.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 18.61M | 70.94% |
| Dec 31, 2025 | 10.89M | - |
| Dec 31, 2024 | 10.89M | 80.16% |
| Dec 29, 2023 | 6.04M | -50.98% |
| Dec 30, 2022 | 12.33M | -57.32% |
| Dec 31, 2021 | 28.89M | -40.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sareum Holdings | 38.11M |
| Arecor Therapeutics | 33.98M |
| ImmuPharma | 25.01M |
| SkinBioTherapeutics | 14.97M |
| Oxford BioDynamics | 12.39M |
| Palatin Technologies | 12.26M |
| Fusion Antibodies | 12.15M |
| Aptamer Group | 11.17M |